TerminatedPhase 1NCT04994977
Intra-Arterial Chemotherapy for Newly Diagnosed, Residual, or Recurrent Atypical Choroid Plexus Papilloma and Choroid Plexus Carcinoma Prior to Second-Look Surgery
Studying Atypical papilloma of choroid plexus
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Weill Medical College of Cornell University
- Principal Investigator
- Mark Souweidane, M.D.Weill Medical College of Cornell University
- Intervention
- Melphalan(drug)
- Enrollment
- 1 enrolled
- Eligibility
- 0-100 years · All sexes
- Timeline
- 2023 – 2025
Study locations (1)
- Weill Cornell Medicine, New York, New York, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04994977 on ClinicalTrials.gov